Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma (Q36421726)

14 August 2017

Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma (English)

1 reference

14 August 2017

Raje N

1

1 reference

14 August 2017

Powles R

2

1 reference

14 August 2017

Horton C

3

1 reference

14 August 2017

Millar B

4

1 reference

14 August 2017

Shepherd V

5

1 reference

14 August 2017

Middleton G

6

1 reference

14 August 2017

Kulkarni S

7

1 reference

14 August 2017

Eisen T

8

1 reference

14 August 2017

Mehta J

9

1 reference

14 August 2017

Singhal S

10

1 reference

14 August 2017

Treleaven J

11

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

75

1 reference

14 August 2017

11

1 reference

14 August 2017

1684-1689

1 reference

Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223521

Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223521

Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223521

High-dose melphalan with autologous bone marrow transplantation for multiple myeloma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223521

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223521

High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223521

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

21 September 2018

1 reference

12 December 2020

Multiple myeloma treated with high dose intravenous melphalan

1 reference

12 December 2020

Intensive treatment of multiple myeloma and criteria for complete remission

1 reference

12 December 2020

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

1 reference

12 December 2020

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma

1 reference

12 December 2020

Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy

1 reference

12 December 2020

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

12 December 2020

Rapid progression of multiple myeloma following G-CSF mobilization

1 reference

12 December 2020

High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting

1 reference

12 December 2020

Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells

1 reference

12 December 2020

Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescue

1 reference

12 December 2020

Kinetics of paraprotein clearance after autografting for multiple myeloma

1 reference

12 December 2020

Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.286

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

9184187

1 reference